A meta-analysis of clinical benefit rates for fulvestrant 500 mg versus alternative therapies for treatment of postmenopausal, estrogen receptor-positive advanced breast cancer | Health & Environmental Research Online (HERO)

Health & Environmental Research Online (HERO)

Print Feedback Export to File

This record has one attached file:

Citation
Tags

HERO ID

6323058

Reference Type

Journal Article

Title

A meta-analysis of clinical benefit rates for fulvestrant 500 mg versus alternative therapies for treatment of postmenopausal, estrogen receptor-positive advanced breast cancer

Author(s)

Robertson, JFR; Zefei, J; Di Leo, A; Ohno, S; Pritchard, KI; Ellis, M; Bradbury, I; Campbell, C

Year

2016

Is Peer Reviewed?

Yes

Journal

Cancer Research
ISSN: 0008-5472
EISSN: 1538-7445

Volume

Issue

4_Supplement

Page Numbers

P5-14-01-P5-14-01

DOI

10.1158/1538-7445.SABCS15-P5-14-01

Web of Science Id

WOS:000375622403208

URL

https://aacrjournals.org/cancerres/article/76/4_Supplement/P5-14-01/615313/Abstract-P5-14-01-A-meta-analysis-of-clinical
Exit